role of glucagon in hypoglycemia
Not Applicable
- Conditions
- Health Condition 1: E08-E13- Diabetes mellitus
- Registration Number
- CTRI/2023/03/050967
- Lead Sponsor
- AIIMS, Raipur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.A confirmed diagnosis of Diabetes on treatment with insulin with or without oral hypoglycemic agents (OHAs) other than insulin secretagogues
2.Informed consent
Exclusion Criteria
1.Pregnancy
2.Chronic kidney disease more than KDIGO stage 3
3.Sepsis
4.Acute coronary syndrome
5.Insulin secretagogue therapy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the correlation between basal serum glucagon level and incident hypoglycemia in DM patients on insulin based therapy during a follow up period of 2 weeks.Timepoint: 14 days
- Secondary Outcome Measures
Name Time Method 1.The correlation between basal serum glucagon level and time in target range in insulin treated DM patients by using CGMS. <br/ ><br>2.The correlation between basal serum C-peptide with time in target range (TIR) <br/ ><br>Timepoint: 14 days